These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 7888102)

  • 21. Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review.
    Ariga T; Miyatake T; Yu RK
    J Neurosci Res; 2010 Aug; 88(11):2303-15. PubMed ID: 20623617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alzheimer disease. Role of beta A4 peptide and cerebral amyloid substance].
    Duyckaerts C; Delaère P; He Y; Seilhean D; Hauw JJ
    Presse Med; 1994 May; 23(18):848-54. PubMed ID: 7937606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha 1-antichymotrypsin in brain aging and disease.
    Abraham CR; Potter H
    Prog Clin Biol Res; 1989; 317():1037-48. PubMed ID: 2513582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease.
    Brückner G; Hausen D; Härtig W; Drlicek M; Arendt T; Brauer K
    Neuroscience; 1999; 92(3):791-805. PubMed ID: 10426522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetics of Alzheimer's disease and the amyloid beta peptide precursor gene.
    Tanzi RE
    Ann Med; 1989; 21(2):91-4. PubMed ID: 2504259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of inflammatory mechanisms for the development of Alzheimer's disease.
    Eikelenboom P; Veerhuis R
    Exp Gerontol; 1999 Jun; 34(3):453-61. PubMed ID: 10433400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal heterogenicity of amyloid protein examined in Alzheimer's disease.
    Pirim I; Erdogan AR; Tan U
    Int J Neurosci; 2004 Jan; 114(1):75-81. PubMed ID: 14660069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of amyloid deposition in Alzheimer's disease.
    Beyreuther K; Bush AI; Dyrks T; Hilbich C; König G; Mönning U; Multhaup G; Prior R; Rumble B; Schubert W
    Ann N Y Acad Sci; 1991; 640():129-39. PubMed ID: 1776729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease: the relationship between the density of senile plaques, neurofibrillary tangles and A4 protein in human patients.
    Armstrong RA; Myers D; Smith CU; Cairns N; Luthert PJ
    Neurosci Lett; 1991 Feb; 123(2):141-3. PubMed ID: 1709265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.
    Bauer J; Strauss S; Schreiter-Gasser U; Ganter U; Schlegel P; Witt I; Yolk B; Berger M
    FEBS Lett; 1991 Jul; 285(1):111-4. PubMed ID: 1712317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains.
    Suh SW; Jensen KB; Jensen MS; Silva DS; Kesslak PJ; Danscher G; Frederickson CJ
    Brain Res; 2000 Jan; 852(2):274-8. PubMed ID: 10678753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease.
    Snow AD; Mar H; Nochlin D; Kresse H; Wight TN
    J Histochem Cytochem; 1992 Jan; 40(1):105-13. PubMed ID: 1370306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
    Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum amyloid P and related molecules associated with the acute-phase response in Alzheimer's disease.
    Kalaria RN
    Res Immunol; 1992; 143(6):637-41. PubMed ID: 1280849
    [No Abstract]   [Full Text] [Related]  

  • 36. The molecular significance of amyloid beta-peptide for Alzheimer's disease.
    Haass C
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(3):118-23. PubMed ID: 8739395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and cellular biology of Alzheimer amyloid.
    Marotta CA; Majocha RE; Tate B
    J Mol Neurosci; 1992; 3(3):111-25. PubMed ID: 1627458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The amyloid peptide and its precursor in Alzheimer's disease.
    Octave JN
    Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
    Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
    Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau protein directly interacts with the amyloid beta-protein precursor: implications for Alzheimer's disease.
    Smith MA; Siedlak SL; Richey PL; Mulvihill P; Ghiso J; Frangione B; Tagliavini F; Giaccone G; Bugiani O; Praprotnik D
    Nat Med; 1995 Apr; 1(4):365-9. PubMed ID: 7585068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.